Be ready to receive COVID-19 jab: Center
New Delhi: The Union health ministry has informed states and union territories that they are likely to receive the first supply of Covid-19 vaccine...
75 persons detected with new UK mutant strain in India
New Delhi: The total number of people who tested positive for the new UK strain of the coronavirus reached 75 on Thursday, the special...
UK imposes mandatory COVID-19 tests for international travellers
International arrivals from anywhere in the world, including India, will now be required to prove a negative COVID-19 test taken up to 72 hours...
IMA asks its members to participate in COVID-19 vaccination drive
The Indian Medical Association on Friday appealed to all its members to actively participate in the COVID-19 vaccination drive across the country.
“As you all...
Brian Urquhart, early leader of United Nations, dies at 101
British diplomat Brian Urquhart, an early leader of the United Nations who played a central role in developing the UN practice of peacekeeping, has...
WHO welcomes India’s COVID-19 vaccine approval
The World Health Organisation on Sunday welcomed India's decision giving emergency use authorisation to COVID-19 vaccines, saying it will help "intensify" and "strengthen" its...
Thailand confirms 745 new coronavirus cases
Thailand has registered 745 new coronavirus cases, with a new death reported in Bangkok, where a semi-lockdown went into effect.
The Centre of COVID-19 Situation Administration said...
Thailand confirms 745 new coronavirus cases
Thailand has registered 745 new coronavirus cases, with a new death reported in Bangkok, where a semi-lockdown went into effect.
The Centre of COVID-19 Situation Administration said...
UK begins Oxford/AstraZeneca COVID-19 vaccine rollout with dialysis patient
The UK on Monday began rolling out the Oxford University vaccine developed by AstraZeneca as protection against COVID-19, with an 82-year-old Oxford-born dialysis patient...
Moderna COVID-19 vaccine shows 94.1 per cent efficacy in trial: Study
Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's COVID-19 vaccine have revealed 94.1 per cent...
